miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- PMID: 22101765
- DOI: 10.1038/nm.2512
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Abstract
Although there is evidence that redox regulation has an essential role in malignancies, its impact on tumor prognosis remains unclear. Here we show crosstalk between oxidative stress and the miR-200 family of microRNAs that affects tumorigenesis and chemosensitivity. miR-141 and miR-200a target p38α and modulate the oxidative stress response. Enhanced expression of these microRNAs mimics p38α deficiency and increases tumor growth in mouse models, but it also improves the response to chemotherapeutic agents. High-grade human ovarian adenocarcinomas that accumulate miR-200a have low concentrations of p38α and an associated oxidative stress signature. The miR200a-dependent stress signature correlates with improved survival of patients in response to treatment. Therefore, the role of miR-200a in stress could be a predictive marker for clinical outcome in ovarian cancer. In addition, although oxidative stress promotes tumor growth, it also sensitizes tumors to treatment, which could account for the limited success of antioxidants in clinical trials.
Comment in
-
Stressed tumor cell, chemosensitized cancer.Nat Med. 2011 Dec 6;17(12):1552-4. doi: 10.1038/nm.2593. Nat Med. 2011. PMID: 22146456 No abstract available.
Similar articles
-
The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.Curr Pharm Des. 2014;20(11):1888-95. doi: 10.2174/13816128113199990523. Curr Pharm Des. 2014. PMID: 23888941
-
Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2392-401. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966949 Free PMC article.
-
miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.Oncotarget. 2016 Dec 6;7(49):81621-81633. doi: 10.18632/oncotarget.13154. Oncotarget. 2016. PMID: 27835595 Free PMC article. Review.
-
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.Clin Transl Oncol. 2015 Oct;17(10):779-87. doi: 10.1007/s12094-015-1303-1. Epub 2015 Jun 11. Clin Transl Oncol. 2015. PMID: 26063644
-
The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.Int J Mol Sci. 2015 Jul 24;16(8):16833-47. doi: 10.3390/ijms160816833. Int J Mol Sci. 2015. PMID: 26213923 Free PMC article. Review.
Cited by
-
Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.Oncogenesis. 2013 Apr 22;2(4):e46. doi: 10.1038/oncsis.2013.9. Oncogenesis. 2013. PMID: 23608753 Free PMC article.
-
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.Cancer Cell. 2013 Feb 11;23(2):186-99. doi: 10.1016/j.ccr.2012.12.020. Cancer Cell. 2013. PMID: 23410973 Free PMC article.
-
Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison.Int J Cell Biol. 2012;2012:762825. doi: 10.1155/2012/762825. Epub 2012 May 13. Int J Cell Biol. 2012. PMID: 22666258 Free PMC article.
-
Novel NRF2-activated cancer treatments utilizing synthetic lethality.IUBMB Life. 2022 Dec;74(12):1209-1231. doi: 10.1002/iub.2680. Epub 2022 Oct 18. IUBMB Life. 2022. PMID: 36200139 Free PMC article. Review.
-
The core genes involved in the promotion of depression in patients with ovarian cancer.Oncol Lett. 2019 Dec;18(6):5995-6007. doi: 10.3892/ol.2019.10934. Epub 2019 Sep 30. Oncol Lett. 2019. PMID: 31788074 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases